Marker Therapeutics, Inc. — Director's Dealing 2015

Nov 13, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2013-03-20

Reporting Person: Grisewood Sherry (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	205	Direct

Footnotes

F1: Represents shares issued for consulting services performed by Ms. Grisewood prior to being a director and such shares are reflected on a post-split basis for the February 2014 100 to 1 reverse stock split.